Why Agilent Technologies Just Paid $950 Million For Biocare Medical

Agilent acquires Biocare for $950M to boost pathology/cancer diagnostics and recurring revenue. Click here to read an analysis of A stock now.
Opinion
GB News on MSNOpinion

Labour's EU 'reset' slams Brexit into reverse as EU regulation shackles Britain's beating heart

British businesses are set to be hammered by new EU regulations under Keir Starmer's EU 'reset'. Charts compiled by think tank Facts4EU in collaboration with Stand for our Sovereignty and CIBUK.Org, ...